Investing Profile

Barbara Schilberg

InvestorFormer CEOVCAdvisor
Managing Director at BioAdvance
Photo of Barbara Schilberg, Managing Director at BioAdvance

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
BioAdvance Managing Director
$1.5M - $5.0M
$3.3M
3
CompanyStageDateRound SizeTotal Raised
Pillo Health
Series AMay 2019$11M
SeedFeb 2017$2M
$13M
Keriton
SeedFeb 2017$1M
$1M
Co-investors: Steve Barsh (GIT1K), Shahram Hejazi (BioAdvance)